| Patent | Date |
|---|
Process And Composition For Stabilization Of Vulnerable Plaque Utilizing A Combination Of A Statin And Omega 3 Fatty Acids
App 20160128967 - JACKOWSKI; George ; et al. | 2016-05-12 |
Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids
Grant 9,248,138 - Jackowski , et al. February 2, 2 | 2016-02-02 |
Method For Treating Obesity With Anti-obesity Formulations And Omega 3 Fatty Acids For The Reduction Of Body Weight In Cardiovascular Disease Patients (cvd) And Diabetics
App 20150272920 - JACKOWSKI; George ; et al. | 2015-10-01 |
Omega 3 Fatty Acid For Use As A Prescription Medical Food And Omega 3 Fatty Acid Diagnostic Assay For The Dietary Management Of Cardiovascular Patients With Cardiovascular Disease (cvd) Who Are Deficient In Blood Epa And Dha Levels
App 20150246012 - JACKOWSKI; George ; et al. | 2015-09-03 |
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
Grant 9,119,826 - Jackowski , et al. September 1, 2 | 2015-09-01 |
Omega 3 Formulations For Treatment Of Risk Factors For Cardiovascular Disease And Protection Against Sudden Death
App 20150224075 - JACKOWSKI; George ; et al. | 2015-08-13 |
Process And Composition For Stabilization Of Vulnerable Plaque Utilizing A Combination Of A Statin And Omega 3 Fatty Acids
App 20150196571 - JACKOWSKI; George ; et al. | 2015-07-16 |
Statin And Omega 3 Fatty Acids For Reduction Of Apolipoprotein-b Levels
App 20150119414 - JACKOWSKI; George ; et al. | 2015-04-30 |
Cholesterol Absorption Inhibitor And Omega 3 Fatty Acids For The Reduction Of Cholesterol And For The Prevention Or Reduction Of Cardiovascular, Cardiac And Vascular Events
App 20150119368 - JACKOWSKI; George ; et al. | 2015-04-30 |
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
Grant 8,951,514 - Jackowski , et al. February 10, 2 | 2015-02-10 |
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
Grant 8,952,000 - Jackowski , et al. February 10, 2 | 2015-02-10 |
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
Grant 8,715,648 - Jackowski , et al. May 6, 2 | 2014-05-06 |
Statin And Omega 3 Fatty Acids For Reduction Of Apolipoprotein-b Levels
App 20130079310 - JACKOWSKI; George ; et al. | 2013-03-28 |
Omega 3 Fatty Acidfor Use As A Prescription Medical Food And Omega 3 Fatty Acid Diagniostic Assay For The Dietary Management Of Cardiovascular Patients With Cardiovascular Disease (cvd) Who Are Deficient In Blood Epa And Dha Levels
App 20130040913 - JACKOWSKI; George ; et al. | 2013-02-14 |
Cholesterol Absorption Inhibitor And Omega 3 Fatty Acids For The Reduction Of Cholesterol And For The Prevention Or Reduction Of Cardiovascular, Cardiac And Vascular Events
App 20130040927 - JACKOWSKI; George ; et al. | 2013-02-14 |
Method For Treating Obesity With Anti-obesity Formulations And Omega 3 Fatty Acids For The Reduction Of Body Weight In Cardiovascular Disease Patients (cvd) And Diabetics
App 20130034535 - JACKOWSKI; George ; et al. | 2013-02-07 |
Omega 3 Formulations For Treatment Of Risk Factors For Cardiovascular Disease And Protection Against Sudden Death
App 20120302639 - JACKOWSKI; George ; et al. | 2012-11-29 |
Diagnostic methods for congestive heart failure
Grant 8,263,351 - Jackowski , et al. September 11, 2 | 2012-09-11 |
Diagnostic Methods For Congestive Heart Failure
App 20110183436 - Jackowski; George ; et al. | 2011-07-28 |
Diagnostic methods for congestive heart failure
App 20090068676 - Jackowski; George ; et al. | 2009-03-12 |
Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
App 20080096286 - Jackowski; George ; et al. | 2008-04-24 |
Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
Grant 7,314,717 - Jackowski , et al. January 1, 2 | 2008-01-01 |
Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
Grant 7,294,688 - Jackowski , et al. November 13, 2 | 2007-11-13 |
Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons
Grant 7,229,638 - Jackowski , et al. June 12, 2 | 2007-06-12 |
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
App 20060292703 - Jackowski; George ; et al. | 2006-12-28 |
Method and kit for diagnosing myocardial infarction
Grant 7,125,726 - Jackowski , et al. October 24, 2 | 2006-10-24 |
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
App 20060211048 - Jackowski; George ; et al. | 2006-09-21 |
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
Grant 7,087,435 - Jackowski , et al. August 8, 2 | 2006-08-08 |
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
Grant 7,049,397 - Jackowski , et al. May 23, 2 | 2006-05-23 |
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
App 20060068505 - Jackowski; George ; et al. | 2006-03-30 |
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
Grant 7,008,800 - Jackowski , et al. March 7, 2 | 2006-03-07 |
Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
Grant 6,998,243 - Jackowski , et al. February 14, 2 | 2006-02-14 |
Biopolymer marker indicative of disease state having a molecular weight of 1525 daltons
App 20060024671 - Jackowski; George ; et al. | 2006-02-02 |
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
App 20060024755 - Jackowski; George ; et al. | 2006-02-02 |
Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
App 20050287599 - Jackowski, George ; et al. | 2005-12-29 |
Diagnostic methods for congestive heart failure
App 20050100964 - Jackowski, George ; et al. | 2005-05-12 |
Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
Grant 6,890,763 - Jackowski , et al. May 10, 2 | 2005-05-10 |
Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons
App 20040224423 - Jackowski, George ; et al. | 2004-11-11 |
Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
App 20040198950 - Jackowski, George ; et al. | 2004-10-07 |
Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
Grant 6,756,476 - Jackowski , et al. June 29, 2 | 2004-06-29 |
Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons
Grant 6,703,366 - Jackowski , et al. March 9, 2 | 2004-03-09 |
Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons
Grant 6,693,080 - Jackowski , et al. February 17, 2 | 2004-02-17 |
Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
Grant 6,677,303 - Jackowski , et al. January 13, 2 | 2004-01-13 |
Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons
Grant 6,627,608 - Jackowski , et al. September 30, 2 | 2003-09-30 |
Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
Grant 6,627,607 - Jackowski , et al. September 30, 2 | 2003-09-30 |
Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons
Grant 6,627,606 - Jackowski , et al. September 30, 2 | 2003-09-30 |
Biopolymer marker indicative of disease state having molecular weight of 2937 daltons
Grant 6,620,786 - Jackowski , et al. September 16, 2 | 2003-09-16 |
Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
Grant 6,620,787 - Jackowski , et al. September 16, 2 | 2003-09-16 |
Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
Grant 6,617,308 - Jackowski , et al. September 9, 2 | 2003-09-09 |
Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
Grant 6,602,855 - Jackowski , et al. August 5, 2 | 2003-08-05 |
Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons
Grant 6,599,877 - Jackowski , et al. July 29, 2 | 2003-07-29 |
Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons
Grant 6,593,298 - Jackowski , et al. July 15, 2 | 2003-07-15 |
Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons
App 20030040602 - Jackowski, George ; et al. | 2003-02-27 |
Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
App 20030013845 - Jackowski, George ; et al. | 2003-01-16 |
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
App 20030004307 - Jackowski, George ; et al. | 2003-01-02 |
Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons
App 20020160533 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons
App 20020160434 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
App 20020160531 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
App 20020160419 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1949 daltons
App 20020160418 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
App 20020160422 - Jackowski, George ; et al. | 2002-10-31 |
Process for diagnosis of physiological conditions by characterization of proteomic materials
App 20020160420 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
App 20020160417 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
App 20020160528 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1536 daltons
App 20020160423 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons
App 20020160532 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
App 20020160529 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons
App 20020161179 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons
App 20020161188 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
App 20020161181 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
App 20020161186 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
App 20020161184 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
App 20020161183 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 2937 daltons
App 20020161177 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
App 20020161182 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
App 20020161187 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1896 daltons
App 20020161180 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons
App 20020161185 - Jackowski, George ; et al. | 2002-10-31 |
Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons
App 20020160958 - Jackowski, George ; et al. | 2002-10-31 |
| 